MergerLinks - Bihua Chen

AcquisitionPrivate EquityPrivateMinority

target

Atea Pharmaceuticals

bidder

Ally Bridge Group

£175m

27 dealmakers

AcquisitionMinorityPrivate EquityPrivateVenture Capital

target

Greenlight Biosciences

bidder

Mls Capital Fund Ii

£81m

12 dealmakers

Cross BorderPrivate EquityMinorityAcquisitionPublic

target

I-MAB

bidder

Hillhouse Capital Group

£315m

33 dealmakers

PrivatePrivate EquityAcquisitionMinorityDomesticVenture Capital

target

Velosbio

bidder

Cormorant Asset Management

£105m

16 dealmakers

Private EquityPrivateDomesticAcquisitionMinority

Medical Equipment

target

Element Science

bidder

The Invus Group

£114m

13 dealmakers

PrivateMinorityAcquisitionCross BorderPrivate EquityVenture Capital

target

BIOATLA

bidder

Soleus Capital

£55m

14 dealmakers

Switzerland

Cross BorderAcquisitionPrivate EquityPrivateMinorityVenture Capital

target

VECTIVBIO

bidder

Cormorant Asset Management

£84m

35 dealmakers

AcquisitionVenture CapitalDomesticMinorityPublicPrivate Equity

target

Miragen Therapeutics

bidder

VENROCK

£70m

19 dealmakers

Private EquityPrivateMinorityAcquisitionVenture CapitalDomestic

target

Neurogene

bidder

Casdin Capital

£85m

14 dealmakers

AcquisitionCross BorderPrivate EquityPrivateMinority

target

Visen Pharmaceuticals

bidder

Orbimed Pe

£111m

13 dealmakers

United Kingdom

MinorityPrivate EquityAcquisitionPrivateCross BorderVenture Capital

target

Centessa Pharmaceuticals

bidder

Janus Henderson Investors

£179m

27 dealmakers

DomesticVenture CapitalPrivate EquityPrivateMinorityAcquisition

target

Artiva Biotherapeutics

bidder

Acuta Capital

value n/a

16 dealmakers

PrivateCross BorderAcquisitionVenture CapitalPrivate EquityMinority

target

Epimab Biotherapeutics

bidder

Octagon Investments

£86m

16 dealmakers

Private EquityDe-SPACReverse TakeoverPrivateDomesticMergerAcquisitionMajority

target

Tango Therapeutics

bidder

Cormorant Asset Management

£257m

32 dealmakers

Cross BorderPrivate EquityAcquisitionPrivateMinorityVenture Capital

Medical Services

target

Icosavax

bidder

Sanofi Ventures

£71m

19 dealmakers

Ireland

MinorityCross BorderPrivate EquityAcquisitionVenture CapitalPrivate

target

Gh Research

bidder

Deerfield Management Company

£91m

20 dealmakers

MinorityAcquisitionVenture CapitalPrivate EquityCross BorderPrivate

target

Elpiscience Biopharmaceutical

bidder

Cormorant Asset Management

£74m

10 dealmakers

Switzerland

AcquisitionCross BorderMinorityPrivatePrivate EquityVenture Capital

target

Numab Therapeutics

bidder

Novo Holdings

£78m

11 dealmakers

AcquisitionPrivateDomesticMinorityPrivate EquityVenture Capital

target

Nikang Therapeutics

bidder

Surveyor Capital

£141m

29 dealmakers

MinorityVenture CapitalAcquisitionDomesticPrivatePrivate Equity

target

Prime Medicine

bidder

T. Rowe Price Group

£227m

17 dealmakers

MinorityAcquisitionPrivate EquityPrivateVenture CapitalCross Border

target

Umoja Biopharma

bidder

Cormorant Asset Management

£148m

14 dealmakers

AcquisitionMinorityCross BorderPrivatePrivate EquityVenture Capital

target

Strata Oncology

bidder

Baird Capital

£64m

11 dealmakers

De-SPACVenture CapitalMergerPrivate EquityAcquisitionMajorityPrivateReverse TakeoverDomestic

target

Greenlight Biosciences

bidder

Xeraya Capital

£866m

39 dealmakers

Venture CapitalAcquisitionMinorityCross BorderPrivate EquityPrivate

target

SHOUTI

bidder

Casdin Capital

£72m

20 dealmakers

Venture CapitalPrivate EquityPrivateCross BorderAcquisitionMinority

target

Chroma Medicine

bidder

Atlas Venture

£93m

12 dealmakers

Switzerland

De-SPACAcquisitionPrivateReverse TakeoverMergerCross Border

target

Moonlake Immunotherapeutics

bidder

Bvf Partners

£169m

44 dealmakers

PrivatePrivate EquityCross BorderMinorityAcquisitionVenture Capital

target

Korro Bio

bidder

Atlas Venture

£85m

14 dealmakers

Canada

PrivatePrivate EquityVenture CapitalCross BorderMinorityAcquisition

target

Ventus Therapeutics

bidder

Andreessen Horowitz

£103m

12 dealmakers

MinorityAcquisitionPrivateCross BorderVenture CapitalPrivate Equity

target

Tessera Therapeutics

bidder

Abu Dhabi Investment Authority (adia)

£230m

26 dealmakers

AcquisitionVenture CapitalCross BorderPrivatePrivate EquityMinority

target

Moma Therapeutics

bidder

Rock Springs Capital

£121m

14 dealmakers

Venture CapitalMinorityPrivate EquityAcquisitionCross BorderPrivate

Medical Equipment

target

Jenavalve Technology

bidder

Gimv

£85m

10 dealmakers

Venture CapitalDomesticPrivate EquityAcquisitionPrivateMinority

target

Chroma Medicine

bidder

Arch Venture Partners

£111m

18 dealmakers

AcquisitionDomesticPrivateMinorityPrivate EquityVenture Capital

target

ENSOMA

bidder

Arix Bioscience

£108m

19 dealmakers

Private EquityCross BorderVenture CapitalAcquisitionMinorityPrivate

Medical Equipment

target

BIVACOR

bidder

Cormorant Asset Management

£14m

5 dealmakers

AcquisitionDomesticMinorityPrivatePrivate EquityVenture Capital

target

Onkure Therapeutics

bidder

Surveyor Capital

£43m

15 dealmakers